In a randomized, double-blind study, the antiemetic efficacy of a single bolus of tropisetron 5 mg (group T, 37 patients), ondansetron 4 mg (group O, 39 patients) or saline (group C, 45 patients) given at induction was compared in a homogeneous group of 121 patients undergoing gynaecological laparotomy and receiving postoperative patient-controlled intravenous morphine for 24 to 48 hours. Fewer group T and group O patients developed severe nausea compared to group C (P<0.01, log rank test in Kaplan-Meier analysis). Group T patients also had lower nausea scores than group O at 8 to 16h (P<0.05). The overall incidences of severe nausea in groups T, O, and C were 5.4%, 17.9%, and 44.4% respectively (P<0.001, group T vs group C; P<0.05 group O vs group C). In conclusion, the 5-hydroxytryptamine3 receptor antagonists tropisetron and ondansetron were superior to placebo in preventing PONV.
TsuiS.L., LoR.J., TongW.N.. A clinical audit for postoperative pain control on 1443 surgical patients. Acta Anaesthesia Sin1995; 24: 137–148.
2.
WatchaM.F., WhiteP.R.Postoperative nausea and vomiting, its etiology, treatment and prevention. Anesthesiology1992; 177: 62–84.
3.
TsuiS.L., TongW.N., IrwinM.G.. The efficacy, applicability and side-effects of postoperative intravenous patient-controlled morphine analgesia: an audit of 1233 Chinese patients. Anaesth Intensive Care1996; 24: 658–664.
4.
TsuiS.L., LeeD.K.W., NgK.F.J., ChanT.Y., ChanW.S., LoJ.W.R.Epidural infusion of bupivacaine 0.0625% plus fentanyl 3.3 μg/ml provides better postoperative analgesia than patient-controlled analgesia with intravenous morphine after gynaecological laparotomy. Anaesth Intensive Care1997; 25: 76–81.
5.
TonerC.C., BroomheadC.J., LittlejohnI.H.. Prediction of postoperative nausea and vomiting using a logistic regression model. Br J Anaesth1996; 76: 347–351.
6.
KennyI.N.C.Risk factors for postoperative nausea and vomiting. Anaesthesia1994; 49: 6–10.
7.
AlexanderR., FennellyM.Comparison of ondansetron, meto-clopramide and placebo as premedicants to reduce nausea and vomiting after major surgery. Anaesthesia1997; 52: 69–78.
8.
ShendeD., MandalN.G.Efficacy of ondansetron and meto-clopramide for preventing postoperative emesis following strabismus surgery in children. Anaesthesia1997; 52: 496–500.
9.
NaguibM., el BakryA.K., KhoshimM.E.. Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy, a randomised, double-blind comparison with placebo. Can J Anaesth1996; 43: 226–231.
10.
HonkavaaraaP.Effect of ondansetron on nausea and vomiting after middle ear surgery during general anaesthesia. Br J Anaesth1996; 76: 316–318.
11.
Ali MelkkilaT., KantoJ., KatevuoR.Tropisetron and meto-clopramide in the prevention of postoperative nausea and vomiting. A comparative, placebo controlled study in patients undergoing ophthalmic surgery. Anaesthesia1996; 51: 232–235.
12.
CapouetV., de PauwC., VernictB.. Single dose i.v. tropisetron in the prevention of postoperative nausea and vomiting after gynaecological surgery. Br J Anaesth1996; 76: 54–60.
13.
AlonE., KocianR., NettP.C., KoechliO.P., BaettigU., GrimaudoV.Tropisetron for the prevention of postoperative nausea and vomiting in women undergoing gynecologic surgery. Anesth Analg1996; 82: 338–341.
14.
DaviesP.R., WarwickP., O'ConnorM.Antiemetic efficacy of ondansetron with patient-controlled analgesia. Anaesthesia1996; 51: 880–882.
15.
ChenP.P., ChuiP.T., GinT.Comparison of ondansetron and metoclopramide for the prevention of post-operative nausea and vomiting after major gynaecological surgery. Euro J Anaesthesiol1996; 13: 485–491.
16.
AlexanderR., LovellA.T., SeingryD., JonesR.M.Comparison of ondansetron and droperidol in reducing postoperative nausea and vomiting associated with patient-controlled analgesia. Anaesthesia1995; 50: 1086–1088.
17.
KaufmannM.A., RosowC., SchnieperP., SchneiderM.Prophylactic antiemetic therapy with patient-controlled analgesia: a double-blind, placebo-controlled comparison of droperidol, metoclopramide and tropisetron. Anesth Analg1994; 78: 988–994.
18.
PerezE.A.Review of the preclinical pharmacology and comparative efficacy of 5-hydroxytryptamine-3 receptor antagonists for chemotherapy-induced emesis. J Clin Oncol1995; 13: 1036–1043.
19.
de BrujinK.M.Tropisetron. A review of the clinical experience. Drugs1992; (Suppl 3): 11–22.
20.
MarkhamA., SorkinE.M.Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting. Drugs1993; 45: 931–952.
21.
van BelleS.J., StamatakisL., BleibergH., CocquytV.F., MichelJ., de BruijnK.M.Dose-finding study of tropisetron in cisplatin-induced nausea and vomitingAnn Oncol1994; 5: 821–825.
22.
PurhonenS., KaukoM., KoskiE.M., NuutinenL.Comparison of tropisetron, droperidol, and saline in the prevention of postoperative nausea and vomiting after gynaecological surgery. Anesth Analg1997; 84: 662–667.
23.
RobertsC.J., MillarJ.M., GoatV.A.The antiemetic effectiveness of droperidol during morphine patient-controlled analgesia. Anaesthesia1995; 50: 559–562.
24.
NgK.F.J., TsuiS.L., YangJ.C.S., HoE.T.F.Comparison of tramadol and tramadol/droperidol mixture for patient-controlled analgesia (PCA). Can J Anaesth1997; 44: 810–815.
